Feasibility study of neoadjuvant chemotherapy with docetaxel/CDGP/5-fluorouracil in resectable esophagus cancer
Not Applicable
- Conditions
- esophagus cancer
- Registration Number
- JPRN-UMIN000014305
- Lead Sponsor
- Department of Medical Oncology, Sapporo Medical University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
(1) No prior chemotherapy regimen. (2) history of drug hypersensitivity. (3) active concomitant malignancy. (4) serious complications (severe heart disease, active infection) (5) pregnant or lactating females. (6) The investigator considers not suitable for the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Completion rate of protocol treatment
- Secondary Outcome Measures
Name Time Method Safety Progression-free survival Overall survival R0 resection rate Operative morbidity